Cargando…
Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study
INTRODUCTION: When and how to intensify treatment in patients with type 2 diabetes (T2D) not achieving glycated hemoglobin (HbA1c) targets with oral antidiabetic drugs (OADs) in clinical practice remains a matter of clinical preference. This pilot study was conducted using the retrospective observat...
Autores principales: | Peng, Xuejun Victor, Ayyagari, Rajeev, Lubwama, Robert, Shi, Lizheng, Price-Haywood, Eboni G., Hollander, Priscilla, Fonseca, Vivian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136385/ https://www.ncbi.nlm.nih.gov/pubmed/32112204 http://dx.doi.org/10.1007/s13300-020-00783-4 |
Ejemplares similares
-
Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonists
por: Rosenstock, Julio, et al.
Publicado: (2020) -
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
por: Baxter, Mike, et al.
Publicado: (2020) -
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists
por: Crabtree, Thomas S. J., et al.
Publicado: (2022) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017) -
Clinical and Economic Benefits Associated With the Achievement of Both HbA(1c) and LDL Cholesterol Goals in Veterans With Type 2 Diabetes
por: Shi, Lizheng, et al.
Publicado: (2013)